Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Martin Richard Teall is active.

Publication


Featured researches published by Martin Richard Teall.


Bioorganic & Medicinal Chemistry Letters | 2003

A new series of potent benzodiazepine γ-secretase inhibitors

Ian Churcher; Kate Ashton; John W. Butcher; Earl E. Clarke; Timothy Harrison; Huw D. Lewis; Andrew Pate Owens; Martin Richard Teall; Susie Williams; Jonathan D.J. Wrigley

Abstract A new series of benzodiazepine-containing γ-secretase inhibitors with potential use in the treatment of Alzheimers disease is disclosed. Structure–activity relationships of the pendant hydrocinnamate side-chain which led to the preparation of highly potent inhibitors are described.


Bioorganic & Medicinal Chemistry Letters | 1994

Acyclic NK-1 antagonists: 2-benzhydryl-2-aminoethyl ethers

Brian John Williams; Martin Richard Teall; Jeffrey Mc Kenna; Timothy Harrison; Christopher John Swain; Margaret A. Cascieri; Sharon Sadowski; Catherine D. Strader; Raymond Baker

Abstract A series of 2-aminoethyl ethers based on diphenylalaninol have been shown to have significant affinity for the human NK 1 receptor and reduced affinity at the L-type Ca ++ channel compared with quinuclidines related to CP 96,345.


Bioorganic & Medicinal Chemistry Letters | 1994

Acyclic NK1 antagonists: Replacements for the benzhydryl group.

Christopher John Swain; Margaret A. Cascieri; Andrew Pate Owens; W. Saari; Sharon Sadowski; Catherine D. Strader; Martin Richard Teall; M.B. van Niel; Brian John Williams

Abstract An exploration of benzhydryl replacements is described. Whilst bridged and fused polynuclear aromatic systems both incur a reduction in affinity it was possible to replace the benzhydryl by a single phenyl ring with only a modest reduction in affinity. In contrast to the analogous diphenylalanyl ethers the binding was also shown to be stereoselective.


Bioorganic & Medicinal Chemistry Letters | 1997

4-Heterocyclyl tetrahydropyridines as selective ligands for the human dopamine D4 receptor

Karen Elizabeth Haworth; Timothy Harrison; Janusz Jozef Kulagowski; Paul D. Leeson; Andrew Pate Owens; Mark Peter Ridgill; Martin Richard Teall; M. Fielding; Kevin T. Chapman; Frances Emms; Rosemary Marwood; Shil Patel; K.L. Moss

Abstract A series of 1,2,3,6-tetrahydropyridines 3 were synthesised, which resulted in selective high affinity dopamine D4 ligands. The SAR of heterocyclic replacements and aromatic substitution was investigated, leading to compounds of nanomolar binding affinity with excellent selectivity over both D2 and D3 receptors.


Bioorganic & Medicinal Chemistry Letters | 1993

4-hydroxyphenoxymethylene bisphosphonic acid derivatives: potent, non-hydrolysable inhibitors of MYO-inositol monophosphatase

Stephen Robert Fletcher; Raymond Baker; Tamara Ladduwahetty; Andrew Sharpe; Martin Richard Teall; John R. Atack

Abstract From a series of 4-hydroxyphenoxymethylene bisphosphonic acid derivatives 1-(4-Hydroxyphenoxy)-1-(methyl)methylenebisphosphonic acid has been identified as a structurally simple, competitive, inhibitor of myo -inositol monophosphatase (IC 50 , 0.33 μM). Replacement of the 1-methyl group by a 3-(3,4-dichlorobenzamido)benzyl substituent affords the most potent inhibitor of the series (IC 50 , 0.08 μM).


Bioorganic & Medicinal Chemistry Letters | 1996

Linear amides as substance P antagonists

Martin Richard Teall; Timothy Harrison; Jonathan D. Moseley; Andrew Pate Owens; Sharon Sadowski; Margaret A. Cascieri

Abstract In the present study we demonstrate that an amide linking group provides an excellent template for the positioning of a benzhydryl group and a suitably functionalized aromatic ring in an orientation which allows for high affinity binding to the hNK1 receptor.


Bioorganic & Medicinal Chemistry Letters | 1992

Inhibitors of myo-inositol monophosphatase unrelated to the enzyme substrate

Stephen Robert Fletcher; Robert K. Baker; Paul D. Leeson; Martin Richard Teall; E.A. Harley; C.I. Ragan

Abstract Hydroxymethylenebisphosphonate derivatives have been found to be competitive inhibitors of myo-inositol monophosphatase.


Archive | 1994

Substituted morpholine derivatives and their use as therapeutic agents

Raymond Baker; Timothy Harrison; Angus Murray Macleod; Andrew Pate Owens; Eileen Mary Seward; Christopher John Swain; Martin Richard Teall


Archive | 1992

Aromatic compounds, pharmaceutical compositions containing them and their use in therapy

Christopher John Swain; Martin Richard Teall; Brian John Williams


Bioorganic & Medicinal Chemistry Letters | 2006

4-Substituted cyclohexyl sulfones as potent, orally active γ-secretase inhibitors

Ian Churcher; Dirk Beher; Jonathan D. Best; José L. Castro; Earl E. Clarke; Amy Gentry; Timothy Harrison; Laure Hitzel; Euan Kay; Sonia Kerrad; Huw D. Lewis; Pablo Morentin-Gutierrez; Russell J. Mortishire-Smith; Paul Joseph Oakley; Michael Reilly; Duncan E. Shaw; Mark S. Shearman; Martin Richard Teall; Susie Williams; Jonathan D.J. Wrigley

Collaboration


Dive into the Martin Richard Teall's collaboration.

Researchain Logo
Decentralizing Knowledge